SCHEMBL7744192

SCHEMBL7744192

CCCCC(=O)Nc1oc(-c2ccc(-c3ccccc3)cc2O)nc1-c1cccc(Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 6/20 0.51
ADORA1 P30542 3/20 0.46
FLT1 P17948 1/20 0.46
FLT4 P35916 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
HPGD P15428 3/20 0.46
USP2 O75604 1/20 0.46
TSHR P16473 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
ADORA3 P0DMS8 1/20 0.43
HCAR2 Q8TDS4 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
ATM Q13315 1/20 0.42
KDM4E B2RXH2 4/20 0.41
ALDH1A1 P00352 3/20 0.41
HSD17B10 Q99714 2/20 0.41
RXRA P19793 1/20 0.40
RXRB P28702 1/20 0.40
RXRG P48443 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7744659 0.93 KDR (0.50) KDRADORA1FLT1FLT4SMN1; SMN2
SCHEMBL7739022 0.92 KDR (0.54) KDRADORA1FLT1FLT4SMN1; SMN2
SCHEMBL7744041 0.90 HPGD (0.46) KDRADORA1FLT1FLT4SMN1; SMN2
SCHEMBL7739075 0.89 KDR (0.42) KDRADORA1FLT1FLT4SMN1; SMN2
SCHEMBL7744162 0.88 KDR (0.45) KDRADORA1FLT1FLT4SMN1; SMN2
SCHEMBL7739007 0.88 KDR (0.51) KDRADORA1FLT1FLT4SMN1; SMN2
SCHEMBL7739078 0.86 KDR (0.68) KDRFLT1FLT4SMN1; SMN2TSHR
SCHEMBL7744194 0.85 ADORA1 (0.46) KDRADORA1FLT1FLT4SMN1; SMN2
SCHEMBL7744651 0.85 HPGD (0.51) KDRADORA1FLT1FLT4SMN1; SMN2
SCHEMBL7746627 0.85 KDR (0.48) KDRADORA1FLT1FLT4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed